Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Unn-Merete Fagerli, MD, PhD, Thorsten Stühmer, PhD, Toril Holien, Randi Utne Holt, PhD, Ove Bruland, PhD, Manik Chatterjee, MD, John Shaughnessy, Jr, PhD, Stephan Mathas, MD, Anders Sundan, MD, Ralf C Bargou, MD, Bernd Dörken, MD, Magne Borset, MD, PhD, Martin Janz, MD

Blood (2010) 116 (21): 1915.

https://doi.org/10.1182/blood.V116.21.1915.1915

Published: 2010

Journal Articles

Effects of Integrin-Linked Kinase (ILK) Inhibitor QLT0267 on Multiple Myeloma Cells and Evaluation of ILK as a Therapeutic Target in Multiple Myeloma.

Thorsten Stühmer, PhD, Torsten Steinbrunn, MD, Evelyn Grella, Ralf C. Bargou, MD PhD

Blood (2007) 110 (11): 3529.

https://doi.org/10.1182/blood.V110.11.3529.3529

Published: 2007

Journal Articles

Role and Regulation of Heat Shock Proteins 90alpha and 90beta in Multiple Myeloma.

Manik Chatterjee, MD, Sarika Jain, Thorsten Stühmer, PhD, Mindaugas Andrulis, MD, Ute Ungethüm, MD, Ralf-Jurgen Kuban, PhD, Kurt Bommert, PhD, Max Topp, MD, Doris Krämer, MD, Hans K. Müller-Hermelink, MD, Herrmann Einsele, MD, Greiner Axel, MD, Ralf C. Bargou, MD

Blood (2006) 108 (11): 5029.

https://doi.org/10.1182/blood.V108.11.5029.5029

Published: 2006

Journal Articles

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma.

Manik Chatterjee, MD, Christoph Ransco, MD, Thorsten Stühmer, PhD, Niels Eckstein, PhD, Hans-Dieter Royer, PhD, Ralf Bargou, MD

Blood (2005) 106 (11): 3385.

https://doi.org/10.1182/blood.V106.11.3385.3385

Published: 2005

Journal Articles

Non-Genotoxic Targeting of p53-Dependent and p53-Independent Signaling Pathways Efficiently Kills Hodgkin/Reed-Sternberg Cells.

Martin Janz, MD, Thorsten Stühmer, PhD, Bernd Dörken, MD, Ralf Bargou, MD

Blood (2005) 106 (11): 964.

https://doi.org/10.1182/blood.V106.11.964.964

Published: 2005

NARROW

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Effects of Integrin-Linked Kinase (ILK) Inhibitor QLT0267 on Multiple Myeloma Cells and Evaluation of ILK as a Therapeutic Target in Multiple Myeloma.

Role and Regulation of Heat Shock Proteins 90alpha and 90beta in Multiple Myeloma.

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma.

Non-Genotoxic Targeting of p53-Dependent and p53-Independent Signaling Pathways Efficiently Kills Hodgkin/Reed-Sternberg Cells.

Email alerts

ASH Publications

American Society of Hematology

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Effects of Integrin-Linked Kinase (ILK) Inhibitor QLT0267 on Multiple Myeloma Cells and Evaluation of ILK as a Therapeutic Target in Multiple Myeloma.

Role and Regulation of Heat Shock Proteins 90alpha and 90beta in Multiple Myeloma.

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma.

Non-Genotoxic Targeting of p53-Dependent and p53-Independent Signaling Pathways Efficiently Kills Hodgkin/Reed-Sternberg Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only